Thus, EEPD1 (and RAD51) overexpression likely confers a selective advantage to cancer cells as they manage multiple types of stress, and it is also likely to confer resistance to replication stress-inducing cancer chemo- and radiotherapeutics [197]. Here, RAD51 is linked to cancer.